Indaptus Therapeutics Inc (NASDAQ:INDP) Announces FDA Clearance: Stock Falls

May 23, 2022

It was a tough day in the markets for investors in the company Indaptus Therapeutics Inc (NASDAQ:INDP) as its stock suffered from a selloff and ended the day with a decline of as much as 8%. Trading Data On Friday, INDP stock fell 7.41% to $2.75 with more than 1.23 million shares, compared to its average volume of 479k shares. The stock moved within a range of $2.3000 – 2.8500…

Read More >>